NHS Trial: Precision-Guided Genome Sequencing Enhances Outcomes for Children with High-Risk Cancers

Jul 2, 2024, 09:57 AM

A recent NHS trial has demonstrated that precision-guided treatment informed by comprehensive molecular profiling significantly improves outcomes for children with high-risk cancers. The trial, reported in Nature Medicine by NaturePortfolio, highlights the benefits of whole genome sequencing in clinical care for children with cancer in England. This cutting-edge genetic test could replace hundreds of other tests, offering a more efficient and effective approach to treatment. The research, covered by SkyNews, supports efforts to make this test available to all children with suspected cancer to help inform individual patient care.